Liquidia (LQDA) Enterprise Value (2020 - 2026)
Liquidia's (LQDA) quarterly Enterprise Value came in at -$222.8 million in Q1 2026, down 31.24% year-on-year from -$324.0 million in Q1 2025, and down 16.84% quarter-over-quarter from -$190.7 million in Q4 2025.
Liquidia (LQDA) Enterprise Value (2020 - 2026) Analysis & Trends
Liquidia's Enterprise Value history runs 7 years deep, the most recent figure standing at -$222.8 million for Q1 2026.
- On a quarterly basis, Enterprise Value fell 31.24% year-over-year to -$222.8 million in Q1 2026; TTM through Mar 2026 was -$222.8 million, a 31.24% decrease from a year earlier, with the FY2025 full-year figure at -$190.7 million, down 8.05% from the prior year.
- Enterprise Value eased to -$222.8 million in Q1 2026 per LQDA's latest filing, from -$190.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$57.8 million in Q1 2022 and bottomed at -$222.8 million in Q1 2026.
- The 5-year median for Enterprise Value is -$133.1 million (2024), against an average of -$134.2 million.
- Across the five-year window, Enterprise Value slumped 168.11% in 2024 and climbed 22.94% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$93.3 million in 2022, then climbed by 10.3% to -$83.7 million in 2023, then slumped by 110.9% to -$176.5 million in 2024, then retreated by 8.05% to -$190.7 million in 2025, then slipped by 16.84% to -$222.8 million in 2026.
- Per Business Quant, the three latest LQDA Enterprise Value figures stand at -$222.8 million (Q1 2026), -$190.7 million (Q4 2025), and -$157.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | -222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -222.79 Mn |
| Dec 31, 2025 | -190.68 Mn |
| Sep 30, 2025 | -157.50 Mn |
| Jun 30, 2025 | -173.42 Mn |
| Mar 31, 2025 | -169.76 Mn |
| Dec 31, 2024 | -176.48 Mn |
| Sep 30, 2024 | -204.37 Mn |
| Jun 30, 2024 | -133.09 Mn |
| Mar 31, 2024 | -157.86 Mn |
| Dec 31, 2023 | -83.68 Mn |
| Sep 30, 2023 | -76.23 Mn |
| Jun 30, 2023 | -88.20 Mn |
| Mar 31, 2023 | -94.41 Mn |
| Dec 31, 2022 | -93.28 Mn |
| Sep 30, 2022 | -98.32 Mn |
| Jun 30, 2022 | -103.84 Mn |
| Mar 31, 2022 | -57.80 Mn |
| Dec 31, 2021 | -57.49 Mn |
| Sep 30, 2021 | -64.10 Mn |
| Jun 30, 2021 | -67.89 Mn |